Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Dendreon Corp.
In Vitro And In Vivo Diagnostic Substances WA, United States
Nasdaq: DNDN
Company Description
Dendreon Corp. is a biotechnology company, which focuses on discovery, development and commercialization of novel therapeutics that improves cancer treatment options for patients. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.
Similar to: Chembio Diagnostics, Inc., Techne Corp., Inovio Pharmaceuticals, Inc.
Featured Company
Aben Resources Ltd.
Vancouver, BC, CA
Aben Resources (TSX.V: ABN) is a Canadian gold and silver exploration company with a focus on developing properties in the Yukon.… Learn more →
Social Monitor
You may also be interested in:
Inovio Pharmaceuticals,…
Blue Bell, PA, US
Inovio Pharmaceuticals, Inc. is dedicated to revolutionizing vaccines to prevent and treat todays cancers and challenging infectious… Learn more →
Techne Corp.
Minneapolis, MN, US
Techne Corp. develops and manufactures biotechnology products and hematology calibrators and controls. The biotechnology division… Learn more →
Chembio Diagnostics, Inc.
Medford, NY, US
Chembio Diagnostics, Inc. (CEMI.QB) through its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures… Learn more →